Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and insights

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Catch up on the latest press releases and download media assets here

Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. Home/
    2. News/
    3. Innovation/
    4. IAS 2017 Conference Paris highlights
    1775614113001-5524684880001-5524671617001-vs.jpg
    Innovation

    IAS 2017 Conference Paris highlights

    July 28, 2017
    July 28, 2017

    More from Johnson & Johnson

    Health & wellness
    October 29, 2025

    Juvenile myasthenia gravis: Inside one adolescent’s journey

    The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.
    Read more
    Innovation
    October 28, 2025

    5 ways Johnson & Johnson is innovating in medicines and therapies

    From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.
    Read more
    Our company
    October 22, 2025

    Johnson & Johnson to collaborate with the New York Jets to promote better health in the community

    Teaming up to support healthcare in the local community and empower residents.
    Read more